New mRNA flu vaccine shows promise in early trial
NCT ID NCT06727058
First seen Jan 31, 2026 · Last updated May 19, 2026 · Updated 17 times
Summary
This study tested a new mRNA vaccine designed to protect against a potential pandemic flu caused by the H5 strain. 276 healthy adults aged 18 and older received either a low, medium, or high dose of the vaccine or a placebo. The main goal was to check safety and see how well the vaccine triggers an immune response, helping researchers pick the best dose for future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA IMMUNIZATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ARSN-Lakeland CRU- Site Number : 8400006
Lakeland, Florida, 33803, United States
-
Accel Research Site - NeuroStudies.net, LLC - ERN - PPDS- Site Number : 8400003
Decatur, Georgia, 30030-2627, United States
-
Accel Research Sites - St. Petersburg- Site Number : 8400004
Largo, Florida, 33777, United States
-
Accel Research Sites Network - DeLand Clinical Research Unit- Site Number : 8400002
DeLand, Florida, 32720, United States
-
Atlanta Clinical Research Center- Site Number : 8400007
Atlanta, Georgia, 30342, United States
-
Charlottesville Medical Research- Site Number : 8400005
Charlottesville, Virginia, 22911, United States
-
Coastal Carolina Research Center - North Charleston- Site Number : 8400001
North Charleston, South Carolina, 29405, United States
-
Olympus Clinical Research - Sugar Land- Site Number : 8400009
Sugar Land, Texas, 77479, United States
-
QUEST Research Institute- Site Number : 8400014
Bingham Farms, Michigan, 48334, United States
-
Velocity Clinical Research - Norfolk- Site Number : 8400015
Norfolk, Nebraska, 68701, United States
-
Velocity Clinical Research - Omaha- Site Number : 8400012
Omaha, Nebraska, 68134, United States
-
Velocity Clinical Research - San Diego- Site Number : 8400013
La Mesa, California, 91942, United States
-
Velocity Clinical Research - Springdale- Site Number : 8400010
Cincinnati, Ohio, 45246, United States
-
Velocity Clinical Research, Salt Lake City- Site Number : 8400011
West Jordan, Utah, 84088, United States
Conditions
Explore the condition pages connected to this study.